Clinical Trials Directory

Trials / Completed

CompletedNCT01357928

Thromboelastography (TEG) Reference Range Study

Procedure for the Reference Range Study for Haemoscope Reagents

Status
Completed
Phase
Study type
Observational
Enrollment
159 (actual)
Sponsor
Haemonetics Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

As part of a system wide reagent verification plan Haemoscope Corporation will be running a study to verify the reference intervals of many of the reagents. Reference intervals will be constructed following the guidelines set out in CLSI document C28-A3c. This guideline calls for a reference interval to be constructed from at least 120 donors. Some reagents currently have ranges in place based on fewer donors than that stated in the guideline. This procedure will provide additional testing results to meet the requirements outlined in the CLSI guideline. Reagents that currently have no reference intervals will be tested and will include a minimum of 146 donors.

Conditions

Timeline

Start date
2011-04-01
Primary completion
2011-07-01
Completion
2011-10-01
First posted
2011-05-23
Last updated
2012-09-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01357928. Inclusion in this directory is not an endorsement.

Thromboelastography (TEG) Reference Range Study (NCT01357928) · Clinical Trials Directory